Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007-2019.
France
GBS
Streptococcus agalactiae
antimicrobial resistance
bacteria
early-onset disease
group B Streptococcus
hypervirulent CC17 clone
late-onset disease
neonatal infections
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
entrez:
20
10
2020
pubmed:
21
10
2020
medline:
16
6
2021
Statut:
ppublish
Résumé
We analyzed group B Streptococcus (GBS) neonatal invasive infections reported during 2007-2019 in France. The hypervirulent clonal complex (CC) 17 GBS was responsible for 66% (827/1,262) of cases. The role of CC17 GBS increased over time (p for trend = 0.0001), together with the emergence of a multidrug-resistant CC17 GBS sublineage.
Identifiants
pubmed: 33079049
doi: 10.3201/eid2611.201669
pmc: PMC7588536
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2721-2724Références
Microbes Infect. 2006 Jun;8(7):1714-22
pubmed: 16822689
Nat Commun. 2014 Aug 04;5:4544
pubmed: 25088811
Lancet Infect Dis. 2014 Nov;14(11):1083-1089
pubmed: 25444407
Clin Microbiol Infect. 2015 Oct;21(10):910-6
pubmed: 26055414
Front Microbiol. 2017 Oct 05;8:1921
pubmed: 29051752
Front Microbiol. 2016 Aug 15;7:1265
pubmed: 27574519
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7424-7430
pubmed: 27736761
J Microbiol Methods. 2010 Feb;80(2):212-4
pubmed: 19958797
Sci Rep. 2016 Feb 04;6:20047
pubmed: 26843175
J Clin Microbiol. 2014 May;52(5):1441-7
pubmed: 24554752
Pediatrics. 2012 Jul;130(1):e8-15
pubmed: 22689869
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S160-S172
pubmed: 29117326
Front Microbiol. 2017 Mar 28;8:499
pubmed: 28400757